Effects of the cannabinoid CB1 receptor antagonist AM 251 on the reinstatement of nicotine-conditioned place preference by drug priming in rats

Pharmacological Reports

Volumn 61, Issue 2, 2009, Pages 304-310

  Budzyńska, Barbara ^a   Kurk, Marta ^a   Biała, Grazyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

AM 251; CB1 cannabinoid receptors; Nicotine; Place conditioning; Rats; Reinstatement

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; NICOTINE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; MALE; NONHUMAN; PLACE PREFERENCE; RAT; RECEPTOR BLOCKING; TOBACCO DEPENDENCE; WISTAR RAT; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY; REINFORCEMENT;

ANIMALS; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; MALE; NICOTINE; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

EID: 67650252199     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70036-2     Document Type: Article

References (31)

1. Biala G, Budzynska B: Calcium-dependent mechanisms of the reinstatement of nicotine-conditioned place preference by drug priming in rats. Pharmacol Biochem Behav, 2008, 89, 116-125.
2. Biala G, Budzynska B: Reinstatement of nicotine-conditioned place preference by drug priming: effects of calcium channel antagonists. Ear J Pharmacol, 2006, 537, 85-93.
3. Caggiula AF, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA, Hoffman A et al.: Environmental stimuli promote the acquisition of nicotine self-administration in rats. Psychopharmacology, 2002, 163, 230-237.
4. Caillé S, Parsons LH: SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats. Eur J Neurosci, 2003, 18, 3145-3149.
5. Calcagnetti DJ, Schechter MD: Nicotine place preference using the biased method of conditioning. Prog Neuropsychopharmacol Biol Psychiatry, 1994, 18, 925-933.
6. Castane A, Valjent E, Ledent C, Parmentier M, Maldonado P, Valverde O: Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology, 2002, 43, 857-867.
7. Chaperon F, Soubrié P, Puech AJ, Thiébot MH: Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology, 1998, 135, 324-332.
8. Cohen C, Perrault G, Griebel G, Soubrié P: Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonists, rimonabant. Neuropsychopharmacology 2005, 30, 145-155.
9. Cohen C, Perrault G, Voltz C, Steinberg R, Soubrié P: SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol, 2002, 13, 451-463.
10. De Vries TJ, Schoffelmeer AN: Cannabinoid CB1 receptors control conditioned drug seeking. Trends Pharmacol Sci, 2005, 26, 420-426.
11. Di Chiari G: Role of dopamine in behavioural actions of nicotine related to addiction. Eur J Pharmacol, 2000, 393, 295-314.
12. Fattore L, Spano S, Cossu G, Deiana S, Fadda P, Fratta W: Cannabinoid CB(1) antagonist SR 141716A attenuates re-instatement of heroin self-administration in heroin-abstinent rats. Neuropharmacology, 2005, 48, 1097-1104.
13. Fiore MC: Public health service clinical practice guideline: treating tobacco use and dependence. Respir Care, 2000, 45, 1200-1262.
14. Frankowska M, Wydra K, Faron-Górecka A, Zaniewska M, Kuśmider M, Dziedzicka-Wasylewska M, Filip M: Alterations in gamma-aminobutyric acid(B) receptor binding in the rat brain after reinstatementof cocaine-seeking behavior. Pharmacol Rep, 2003, 60, 834-843.
15. Freedland CS, Sharpe AL, Samson HH, Porrino LJ: Effects of SR141716A on ethanol and sucrose self-administration. Alcohol Clin Exp Res, 2001, 25, 277-282.
16. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC et al.: International Union of Pharmacology. XXVII. Classification. of cannabinoid receptors. Pharmacol Rev, 2002, 54, 161-202.
17. Koob GF, Weiss F, Tiffany ST, Zieglgansberger W, Spanagel R: Animal models of craving: a roundtable discussion. Alcohol Res Health, 1999, 23, 233-236.
18. Le Foll B, Goldberg SR: Rimonabant, a CB1 antagonist, block nicotine-conditioned place preference. Neuroreport, 2004, 15, 2139-2143.
19. Mansvelder HD, McGehee DS: Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron, 2000, 27, 349-357.
20. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL: Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci, 2004, 24, 53-62.
21. Mueller D, Perdikaris D, Stewart J: Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference. Behav Brain Res, 2002, 136, 389-397.
22. O'Brien CP, Childress AR, McLellan AT, Ehrman R: Classical conditioning in drug-dependent humans. Ann NY Acad Sci, 1992, 654, 400-415.
23. Przegaliński E, Gołda A, Filip M: Effects of serotonin (5-HT)(1B) receptor ligands on cocaine-seeking behavior in rats. Pharmacol Rep, 2008, 60; 798-810.
24. Shoaib M: The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats. Neuropharmacology, 2008, 54, 438-444.
25. Sinha R: How does stress increase risk of drug abuse and relapse? Psychopharmacology, 2001, 158, 343-359.
26. Spanagel R, Weiss F: The dopamine hypothesis of reward: pastand current status. Trends Neurosci; 1999, 22, 521-527.
27. Spyraki C, Fibiger HC, Phillips AG: Doparminergic, substrates of amphetamine-induced place preference conditioning. Brain Res, 1982, 253, 185-193.
28. Szabo B, Siemes S, Wallmichrath I: Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur J Neurosci, 2002, 15, 2057-2061.
29. Tzschentke TM: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol, 2007, 12, 227-462.
30. Valjent E, Mitchell JM, Besson MY, Caboche J, Maldonado R: Behavioural and biochemical evidence for interactions between delta 9-tetrahydrocannabinol and nicotine. Br J Pharmacol, 2002, 135, 564-578.
31. Xi ZX, Gilbert JG, Peng XQ, Pak AC, Li X, Gardner EL: Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens. J Neurosci, 2006, 26, 8531-8536.